Obtained U.S. FDA Drug Registration Approval for Nicardipine Hydrochloride Injection
August 25, 2025
Source: drugdu
89
SecuritiesDaily News Network reported on the evening of August 21 that Jianyou SharesThe company recently received an approval letter from the U.S. Food and Drug Administration (FDA) for nicardipine hydrochloride injection, 25mg/10mL (2.5mg/mL), according to an announcement.
https://finance.eastmoney.com/a/202508213490940546.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Breaking the Mold and Forging a New Path! From Insulin Technology Pioneer to Global Innovation Competitor December 4, 2025
- A subsidiary of Kingfriend Pharmaceutical Co., Ltd. has received FDA approval for its self-developed injectable dapavancin December 4, 2025
- Major ophthalmic new drug successfully completed Phase III trials December 4, 2025
- Simcere Pharmaceutical and Wangshan Wangshui have reached an exclusive licensing agreement for deuterium remidevir hydrobromide for new indications such as RSV infection December 4, 2025
- SAL0140 tablets approved for clinical trials for the treatment of chronic kidney disease December 4, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
